Regulatory Updates
🌏 NMPA Page 5NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 49–60 of 87 articles
Brenus Pharma's STC-1010 IND Application Accepted by FDA
India Strengthens Vietnam Relations Amid Regional Diplomacy
Rusan Pharma Launches State-of-the-Art API Facility in Pithampur
Nuance Pharma Secures IND Clearance for Actair® in China
Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment
60 Degrees Pharmaceuticals Initiates Clinical Trial for Tafenoquine in Babesiosis Patients
Bukwang Pharmaceutical Partners with DreamCIS and AWS for Clinical Trials
Rusan Pharma Achieves Global GMP Milestone with PMDA Approval
Health News Round-Up: Immunotherapy, PCOS, and Clopidogrel Trials
Clinical Trials Day 2026: Oncology Study Growth Insights
Kelun-Biotech's ASCO 2026 Presentation: Key Insights on NSCLC
Merck's TroFuse-005 Trial Results: Implications for Investors and Pharma Teams